HIV-1 drug resistance and resistance testing

DS Clutter, MR Jordan, S Bertagnolio… - Infection, Genetics and …, 2016 - Elsevier
The global scale-up of antiretroviral (ARV) therapy (ART) has led to dramatic reductions in
HIV-1 mortality and incidence. However, HIV drug resistance (HIVDR) poses a potential …

HIV-1 antiretroviral resistance: scientific principles and clinical applications

MW Tang, RW Shafer - Drugs, 2012 - Springer
The efficacy of an antiretroviral (ARV) treatment regimen depends on the activity of the
regimen's individual ARV drugs and the number of HIV-1 mutations required for the …

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society–USA panel

MA Thompson, JA Aberg, P Cahn, JSG Montaner… - Jama, 2010 - jamanetwork.com
Context Recent data regarding the consequences of untreated human immunodeficiency
virus (HIV) infection and the expansion of treatment choices for antiretroviral-naive and …

Challenges and opportunities in estimating viral genetic diversity from next-generation sequencing data

N Beerenwinkel, HF Günthard, V Roth… - Frontiers in …, 2012 - frontiersin.org
Many viruses, including the clinically relevant RNA viruses HIV (human immunodeficiency
virus) and HCV (hepatitis C virus), exist in large populations and display high genetic …

Deep sequencing: becoming a critical tool in clinical virology

ME Quiñones-Mateu, S Avila, G Reyes-Teran… - Journal of clinical …, 2014 - Elsevier
Population (Sanger) sequencing has been the standard method in basic and clinical DNA
sequencing for almost 40 years; however, next-generation (deep) sequencing …

Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients

LC Swenson, T Mo, WWY Dong, X Zhong… - Journal of Infectious …, 2011 - academic.oup.com
Abstract Background. The Maraviroc versus Optimized Therapy in Viremic Antiretroviral
Treatment-Experienced Patients (MOTIVATE) studies compared maraviroc versus placebo …

Clinical significance of HIV-1 coreceptor usage

H Schuitemaker, AB van't Wout, P Lusso - Journal of translational …, 2011 - Springer
The identification of phenotypically distinct HIV-1 variants with different prevalence during
the progression of the disease has been one of the earliest discoveries in HIV-1 biology, but …

Deep V3 sequencing for HIV type 1 tropism in treatment-naive patients: a reanalysis of the MERIT trial of maraviroc

LC Swenson, T Mo, WWY Dong, X Zhong… - Clinical infectious …, 2011 - academic.oup.com
Background. Deep sequencing is a highly sensitive technique that can detect and quantify
the proportion of non-R5 human immunodeficiency virus (HIV) variants, including small …

Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism

J Archer, J Weber, K Henry, D Winner, R Gibson, L Lee… - PloS one, 2012 - journals.plos.org
HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-
R5) viruses prior treatment with CCR5 antagonists. Phenotypic (eg, Trofile™, Monogram …

Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation …

RM Gibson, AM Meyer, D Winner, J Archer… - Antimicrobial agents …, 2014 - Am Soc Microbiol
With 29 individual antiretroviral drugs available from six classes that are approved for the
treatment of HIV-1 infection, a combination of different phenotypic and genotypic tests is …